Tumor vasculature: a sally port for inhibiting cancer cell spreading

Chao-Nan Qian1, Francesco Pezzella2

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. qianchn@sysucc.org.cn.

Insights

Tumor blood vessel development is crucial for metastasis. Experts discussed how solid tumors hijack existing blood vessels, a process called vessel co-option, to grow and spread.

Area of Science:

  • Oncology
  • Angiogenesis Research
  • Cancer Biology

Background:

  • The link between tumor vascularization and metastasis is a key area of cancer research.
  • Inhibiting tumor blood vessel development is a strategy to suppress cancer spread.
  • Solid tumors utilize diverse mechanisms to establish their vasculature.

Framework:

  • The 4th International Meeting of Cancer and Blood Vessels convened experts to discuss tumor vascularization.
  • Focus was placed on vessel co-option as a critical mechanism for tumor growth and metastasis.
  • Discussions covered the underlying biological mechanisms and therapeutic potential.

Implementation:

  • Experts explored how solid tumors co-opt existing or newly formed blood vessels in surrounding tissues.
  • The role of pericytes in supporting tumor vasculature was examined.
  • Potential novel therapeutic targets for anti-angiogenic strategies were identified.

Implications:

  • Understanding vessel co-option offers new avenues for anti-cancer therapies.
  • Targeting tumor vasculature can potentially inhibit metastasis and improve patient outcomes.
  • Further research into pericyte function and therapeutic targets is warranted.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.5K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K